If you've been quietly researching GLP-1 medications late at night, you've probably hit a wall of confusing terms: brand-name, compounded, injectable, oral, FDA-approved. Here's a plain-English breakdown of what those words actually mean, so you can walk into your first visit asking the right questions.
This article is educational and is not medical advice. Whether any medication is appropriate for you is a decision only an independent licensed provider can make after reviewing your health history.
First, what a GLP-1 medication actually is
GLP-1 stands for glucagon-like peptide-1, a hormone your gut naturally releases after you eat. It helps signal fullness and influences how your body manages blood sugar [1]. GLP-1 receptor agonist medications (molecules like semaglutide and tirzepatide) are designed to mimic that signaling. They were first studied and approved for type 2 diabetes, and certain products were later approved for chronic weight management in people who meet specific criteria [2][3].
That's the science most coverage skips. These aren't appetite "willpower" pills — they work with a hormone pathway your body already uses. Understanding that can take some of the shame out of the conversation: decades of yo-yo dieting aren't a character flaw, and biology is part of the picture.
Brand-name vs. compounded: the core difference
This is the distinction that matters most before your first script.
Brand-name medications are manufactured by a pharmaceutical company and reviewed by the U.S. Food and Drug Administration (FDA) for safety, effectiveness, and quality before they reach pharmacies [2][3]. When you see an FDA-approved GLP-1 product, it has gone through that formal review and carries an approved label describing who it's for and how it's used.
Compounded medications are different. Compounding is when a licensed pharmacy or outsourcing facility prepares a medication tailored to a specific need — for example, when a patient can't use a standard product, or during a documented shortage [4]. Compounded drugs serve a real purpose in medicine, but they are not the same as brand-name drugs in one important way:
> Compounded medications are not reviewed or approved by the FDA for safety, effectiveness, or quality. Compounded products are not equivalent to or interchangeable with any FDA-approved brand-name drug. Availability varies by state.
The FDA has specifically cautioned consumers about compounded semaglutide and tirzepatide, including reports of dosing errors and the use of salt forms that differ from the approved active ingredient [4][5]. None of this means compounding is inherently unsafe — it means the oversight layer is different, and that's exactly what you should be asking about.
Source: [2] FDA: Wegovy (semaglutide) injection — Prescribing Information / Drug Approval, [3] FDA: Zepbound (tirzepatide) injection — Drug Approval Package, [4] FDA: Medications Containing Semaglutide Marketed for Type 2 Diabetes or Weight Loss
The needle question: injectable vs. oral
If the idea of injecting yourself at home makes you queasy, you are far from alone — even people who give shots professionally can feel differently about doing it to themselves. So it's worth knowing the landscape.
Most GLP-1 products that reach the public conversation are injectables, typically given once a week [2][3]. There is also an FDA-approved oral form of semaglutide, taken as a daily tablet, originally approved for type 2 diabetes [6]. Whether an oral option is appropriate for any individual is, again, a provider decision — and it depends on your health history and goals.
A few honest points for anyone considering starting:
- An oral path exists, but it isn't automatically the right fit for everyone, and not every product is interchangeable.
- If you are pregnant, breastfeeding, or planning pregnancy, this is essential information to share. GLP-1 medications are generally not recommended in pregnancy, and the approved labels carry specific guidance — so a provider needs the full picture before anything is considered [2][6].
- A prescription is never guaranteed. It's the outcome of a real clinical conversation, not a checkbox.
Side effects: what the labels actually say
You've probably heard the scary stories. Here's the grounded version. The most commonly reported side effects of GLP-1 medications are gastrointestinal — nausea, vomiting, diarrhea, and constipation — and they tend to be reported most when starting or increasing a dose [1][2]. The approved labeling also describes more serious potential risks, including pancreatitis and gallbladder problems, and a boxed warning related to thyroid C-cell tumors observed in rodent studies, which is why certain personal and family medical histories matter [2].
This is exactly why "how you start" and "who is monitoring you" matter more than which brand name is trending. A provider reviews your history to weigh these considerations — that's the part a seven-minute rushed visit usually skips.
Source: [1] Glucagon-Like Peptide-1 Receptor Agonists (StatPearls/NIH NCBI Bookshelf), [2] FDA: Wegovy (semaglutide) injection — Prescribing Information / Drug Approval
Questions worth bringing to your first visit
You deserve a visit where someone actually engages with your options. Here's a practical checklist:
1. Is this product brand-name (FDA-approved) or compounded? If compounded, ask why, and ask about the pharmacy's licensing and quality practices.
2. What's the active molecule, and what form is it in? (For compounded products, the salt-form question above is relevant [4][5].)
3. Are there oral as well as injectable options to discuss for my situation?
4. Given my history — including pregnancy or breastfeeding status — what should I know about safety and monitoring?
5. What lab work do you want before and during? (Baseline metabolic markers are commonly part of the picture [1].)
6. What follow-up looks like if side effects show up.
7. What is the total cost, including the product and any follow-up — so there are no surprises on a tight budget.
You are allowed to ask all of these. A provider who takes you seriously will welcome them.
Source: [1] Glucagon-Like Peptide-1 Receptor Agonists (StatPearls/NIH NCBI Bookshelf), [7] Endocrine Society Clinical Practice Guideline: Pharmacological Management of Obesity
A note on the bigger picture
GLP-1 medications are tools, not magic. Major medical organizations frame obesity as a chronic, complex condition — not a willpower problem — and recommend care that combines lifestyle support with medical options where appropriate [7]. If your knees and back already ache, "just exercise more" was never adequate advice. The goal is a plan that fits your real life: kids, night shifts, no sleep, and a school-district budget included.
Where Velri fits
Velri is a technology and coordination company — not a medical practice. We don't provide medical care or guarantee any prescription. What we do is make the process less overwhelming: we help coordinate lab work, connect you with an independent, licensed provider who can actually take the time to review your history and answer the questions above, and — if that provider determines a medication is appropriate for you — coordinate fulfillment through an independent, licensed pharmacy.
That means you get a real conversation about brand-name versus compounded options, injectable versus oral considerations, and what monitoring looks like — without the seven-minute brush-off. The decision always rests with the independent provider, and this article remains educational, not medical advice.
*Reminder on compounded options: Compounded medications are not reviewed or approved by the FDA for safety, effectiveness, or quality. Compounded products are not equivalent to or interchangeable with any FDA-approved brand-name drug. Availability varies by state.*
